@ARTICLE{
author={Weiss Jared|,Goldschmidt Jerome|,Andric Zoran G|0000-0002-1495-2729,Dragnev Konstantin H|,Gwaltney Chad|,Skaltsa Konstantina|,Pritchett Yili|,Antal Joyce M|,Morris Shannon R|,Daniel Davey|},
year={2021},
title={Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies},
journal={CLINICAL LUNG CANCER},
volume={22},
number={5},
pages={449-460},
document_type={Article},
} 

@ARTICLE{
author={Hart Lowell L|,Ferrarotto Renata|,Andric Zoran G|0000-0002-1495-2729,Beck Thaddeus J|,Subramanian Janakiraman|,Radosavljevic Davorin Z|,Zaric Bojan|0000-0003-3215-8390,Hanna Wahid T|,Aljumaily Raid|,Owonikoko Taofeek K|,Verhoeven Didier|,Xiao Jie|,Morris Shannon R|,Antal Joyce M|,Hussein Maen A|},
year={2021},
title={Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study},
journal={ADVANCES IN THERAPY},
volume={38},
number={1},
pages={350-365},
document_type={Article},
}